The trademark PlusQuam PHARMA was filed by PlusQuam Pharma, S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on September 18, 2022, and received one opposition filed on October 12, 2022 by +PHARMA ARZNEIMITTEL GMBH on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by WILTSCHEK PLASSER RECHTSANWÄLTE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 12, 2022
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003180662 was rejected according to Article 8(1)(b) EUTMR with decision issued on May 16, 2024 by the EUIPO. The Appeal with reference B R1217/2024-2 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on November 6, 2024 by the EUIPO.